JC Krause, T Tsibane, TM Tumpey… - Journal of …, 2011 - Am Soc Microbiol 1 REVISION: JVI00700-11 1 A broadly neutralizing human monoclonal antibody that recognizes a conserved, 2 novel epitope on the globular head of influenza H1N1 virus hemagglutinin 3 ... Page 2. 2 The conserved influenza virus hemagglutinin (HA) stem domain elicits cross- 1 ... Cited by 1
[HTML] from plos.orgSE Hensley, SR Das, JS Gibbs, AL Bailey… - PLoS One, 2011 - dx.plos.org Drugs inhibiting the influenza A virus (IAV) neuraminidase (NA) are the cornerstone of anti-IAV chemotherapy and prophylaxis in man. Drug-resistant mutations in NA arise frequently in human isolates, limiting the therapeutic application of NA inhibitors. Here, we show that antibody- ... Cited by 5 - Related articles - Cached - All 5 versions
P Pushko, MB Pearce, A Ahmad, I Tretyakova… - Vaccine, 2011 - Elsevier Despite existing vaccines and specific therapies, epidemics of seasonal influenza annually claim 200,000–500,000 lives worldwide. Pandemic influenza represents an even greater threat, with numerous potentially pandemic viruses circulating in nature. Development of ... Related articles - All 2 versions
[PDF] from nih.govJL Lorieau, JM Louis… - Journal of the American Chemical …, 2011 - ACS Publications The fusion domain of the influenza coat protein hemagglutinin HA2, bound to dodecyl phosphocholine micelles, was recently shown to adopt a structure consisting of two antiparallel α-helices, packed in an exceptionally tight hairpin configuration. Four interhelical H α to C═O aliphatic H- ... Related articles - All 5 versions
R Harvey, KA Guilfoyle, S Roseby… - Journal of …, 2011 - Am Soc Microbiol The candidate pandemic H1N1 vaccine virus NIBRG-121 was derived by reverse genetics and comprises the hemagglutinin (HA) and neuraminidase (NA) genes from A/California/7/2009 (CAL) on an A/Puerto Rico/8/34 (PR8) backbone. NIBRG-121 was found to grow poorly in ... Related articles - All 3 versions